EUVIMEDEUVIMED entdecken
Systematische Übersicht

Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review

Blair Murphy, Andrew Jackson, Johnnie K Bass, Derek S Tsang, Cecile M Ronckers, Leontien Kremer, Sujith Baliga, Arthur Olch, Andrew H Zureick, Kyung-Wook Jee, Louis S Constine, Torunn I Yock

International Journal of Radiation Oncology*Biology*Physics · 2024-06 · 119 (2) · 446-456

DOI: 10.1016/j.ijrobp.2023.08.016 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024-06. Verfasst von Blair Murphy und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Medicine, Oregon Health & Science University, Doernbecher Children's Hospital, Portland, Oregon. Electronic address: murphbl@…. Hauptthemen laut MEDLINE: Hearing Loss, Cochlea, Cancer Survivors. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: American Association of Physicists in Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The Pediatric Normal Tissue Effects in the Clinic (PENTEC) hearing loss (HL) task force reviewed investigations on cochlear radiation dose-response relationships and risk factors for developing HL. Evidence-based dose-response data are quantified to guide treatment planning. METHODS AND MATERIALS: A systematic review of the literature was performed to correlate HL with cochlear dosimetry. HL was considered present if a threshold exceeded 20 dB at any frequency. Radiation dose, ototoxic chemotherapy exposure, hearing profile including frequency spectra, interval to HL, and age at radiation therapy (RT) were analyzed. RESULTS: Literature was systematically reviewed from 1970 to 2021. This resulted in 739 abstracts; 19 met inclusion for meta-analysis, and 4 included data amenable to statistical modeling. These 4 studies included 457 cochleas at risk in patients treated with RT without chemotherapy, and 398 cochlea treated with chemotherapy. The incidence and severity of cochlear HL from RT exposure alone is related to dose and age. Risk of HL was 3 years of age. High-frequency HL was most common, with average onset occurring 3.6 years (range, 0.4-13.2 years) after RT. Exposure to platinum-based chemotherapies added to the rates of HL at a given cochlear dose level, with 300 mg/m2 shifting the dose response by 7 Gy. CONCLUSIONS: In children treated with RT alone, risk of HL was low for cochlear dose

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hearing LossCochleaCancer SurvivorsHumansChildChild, PreschoolDose-Response Relationship, RadiationAdolescentAge FactorsRisk FactorsInfantRadiotherapyRadiotherapy DosageOrgans at Risk

Autor:innen und Institutionen

  • Department of Radiation Medicine, Oregon Health & Science University, Doernbecher Children's Hospital, Portland, Oregon. Electronic address: murphbl@ohsu.edu.
  • Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rehabilitation Services, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, The Netherlands; Division of Childhood Cancer Epide…
  • Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Emma Children's Hospital, Amsterdam UMC Location AMC, Amsterdam, The Netherlands.

Förderung

  • American Association of Physicists in Medicine

Zitieren

APA

Murphy, B., Jackson, A., Bass, J. K., Tsang, D. S., Ronckers, C. M., Kremer, L., Baliga, S., Olch, A., Zureick, A. H., Jee, K. W., Constine, L. S., & Yock, T. I. (2024). Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review. International Journal of Radiation Oncology*Biology*Physics, 119(2), 446-456. https://doi.org/10.1016/j.ijrobp.2023.08.016

Vancouver

Murphy B, Jackson A, Bass JK, Tsang DS, Ronckers CM, Kremer L, et al. Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review. International Journal of Radiation Oncology*Biology*Physics. 2024;119(2):446-456. doi:10.1016/j.ijrobp.2023.08.016

BibTeX
@article{Murphy2024,
  author = {Murphy, Blair and Jackson, Andrew and Bass, Johnnie K and Tsang, Derek S and Ronckers, Cecile M and Kremer, Leontien and Baliga, Sujith and Olch, Arthur and Zureick, Andrew H and Jee, Kyung-Wook and Constine, Louis S and Yock, Torunn I},
  title = {Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2024},
  volume = {119},
  number = {2},
  pages = {446--456},
  doi = {10.1016/j.ijrobp.2023.08.016}
}
Kostenlos starten →